Winrevair, also known as sotatercept-csrk, is a medicine used to treat pulmonary arterial hypertension (PAH), which causes high blood pressure in the arteries that go from your heart to your lungs.

This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello, and welcome to this podcast series. I'm Dr Vallerie McLaughlin, the Kim A. Eagle Endowed Professor of Cardiovascular ...

High blood pressure can indirectly cause shortness of breath by forcing the heart to work harder, which may lead to cardiovascular issues. Pulmonary hypertension, a specific type of high blood ...

ATS 2024, San Diego – The use of hormone replacement therapy (HRT) may be associated with improved pulmonary hypertension in women, according to research presented at the ATS 2024 International ...

A study found that pulmonary hypertension often resolves within a year in premature infants with BPD, though many still ...

Dr. Alison S. Witkin: A 21-year-old male college student was evaluated in the cardiology clinic at this hospital, before the coronavirus disease 2019 pandemic, because of progressive dyspnea. When the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “From 2012, our team and other teams have provided some ...

The use of hormone replacement therapy (HRT) may be associated with improved pulmonary hypertension in women, according to research presented at the ATS 2024 International Conference. Pulmonary ...

Individualized treatment and close monitoring are essential for pregnant women with pulmonary hypertension due to high maternal and fetal risks. Prognosis in pulmonary hypertension varies with ...